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1. Introduction
Metal halide perovskites, ABX3 (A = methylammonium (MA), 
formamidinium (FA) or Cs; B = Pb or Sn; X = I, Br, Cl) have 
The excellent optoelectronic properties demonstrated by hybrid organic/
inorganic metal halide perovskites are all predicated on precisely controlling 
the exact nucleation and crystallization dynamics that occur during film 
formation. In general, high-performance thin films are obtained by a method 
commonly called solvent engineering (or antisolvent quench) processing. The 
solvent engineering method removes excess solvent, but importantly leaves 
behind solvent that forms chemical adducts with the lead-halide precursor 
salts. These adduct-based precursor phases control nucleation and the growth 
of the polycrystalline domains. There has not yet been a comprehensive study 
comparing the various antisolvents used in different perovskite compositions 
containing cesium. In addition, there have been no reports of solvent 
engineering for high efficiency in all-inorganic perovskites such as CsPbI3. In 
this work, inorganic perovskite composition CsPbI3 is specifically targeted and 
unique adducts formed between CsI and precursor solvents and antisolvents 
are found that have not been observed for other A-site cation salts. These 
CsI adducts control nucleation more so than the PbI2–dimethyl sulfoxide 
(DMSO) adduct and demonstrate how the A-site plays a significant role in 
crystallization. The use of methyl acetate (MeOAc) in this solvent engineering 
approach dictates crystallization through the formation of a CsI–MeOAc 
adduct and results in solar cells with a power conversion efficiency of 14.4%.
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shown a higher level of tolerance to 
material and crystallization defects than 
any other optoelectronic semiconductor 
family. This has enabled fabrication of 
high-quality semiconductors from facile 
methods such as solution processing. 
As such, researchers have been able to 
demonstrate impressive performance 
in photovoltaic devices with single junc-
tion power conversion efficiency (PCE) 
exceeding 25% and tandem cell efficiency 
surpassing 28% under AM1.5G simulated 
sunlight.[1,2] The combination of high 
performance and low-cost production is 
enabling perovskite solar cell commercial-
ization.[3,4] However, defect tolerance does 
not mean that any defects, commonly 
formed during film fabrication, are com-
pletely benign. One of the biggest break-
throughs in halide perovskites was the 
introduction of the solvent engineering 
approach, which produces high-quality, 
pinhole-free, device-grade thin films by 
taking advantage of specific precursor sol-
vent interactions coupled with a nucleating 
antisolvent drip.[5] This approach was first 
demonstrated with MAPbI3 in 7:3 gamma-
butyrolactone (GBL):dimethyl sulfoxide (DMSO) using toluene 
as the antisolvent and has become a universal and reproducible 
method for many groups to achieve high efficiency perovskite 
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solar cells using a variety of perovskite compositions, such as 
complex compositions commonly called the triple A-site cation 
formulation, which is CsxFAyMA1−x−yPb(IzBr1−z)3.[5–7] However, 
extending this approach toward other compositions requires 
insight into the various adducts formed between precursors 
and solvents, as well as the interaction between the perovskite 
film and the crystallization initiator (i.e. antisolvent).[8,9]
While DMSO has always been considered a good solvent 
for hybrid Pb-halide perovskites, early on it was abandoned 
for dimethylformamide (DMF) because DMSO slows the 
crystallization, whereas DMF evaporates cleanly and rapidly, 
leading to films with better morphology.[5,10,11] DMSO forms 
a strong adduct with PbI2 which retards perovskite crystalli-
zation through first forming a MAI–DMSO–PbI2 crystalline, 
“precursor” phase, which then converts to the 3D ABX3 perov-
skite phase upon annealing.[11] The solvent engineering method 
exploits this effect by using a mixture of DMF and DMSO to 
control the crystallization rate by tuning the solvent ratio and 
thus the amount of PbI2–DMSO complex. An antisolvent 
quench is also incorporated to intentionally control the exact 
nucleation time through the introduction of an antisolvent 
that supersaturates the precursor solution and removes excess 
precursor solvent.[5,12–14] The antisolvent quench must happen 
within a specific nucleation window since quenching too early 
will not cause supersaturation and quenching after the film 
has already begun to nucleate will not induce the ideal nuclea-
tion site density.[15–17] When the quenching occurs within this 
window, heterogeneous nucleation is promoted at the initial 
crystallization stage and minimizes pinholes in the resulting 
films.[9,13] By controlling nucleation and slowing down the 
crystallization, the perovskite films have more uniform film 
coverage.
Although the use of solvent controlled crystallization has 
been used for many perovskite compositions, a fundamental 
understanding of how this mechanism works for all composi-
tions is lacking. High-efficiency perovskite solar cells utilizing 
the triple cation formulation have been shown to have PCE 
exceeding 20%, low radiative loss, and stability for thousands 
of hours under certain stressing conditions.[6,18,19] CsI is incor-
porated to improve both film quality and stability, often through 
minimizing I/Br halide phase segregation under illumination, 
which is critical for use in high-performance perovskite tan-
dems.[20–24] The precursor solutions to create such films contain 
many salts that may interact in various ways. Recent reports 
have shown that the introduction of low amounts of CsI (<15%) 
further retards crystallization in mixed cation perovskites 
because more DMSO stays in the as-cast, preannealed film, 
resulting in higher quality films following crystallization.[25] 
Additionally, the introduction of CsI lowers the formation 
energy of the cubic perovskite phase as compared to interme-
diate phases thus promoting crystallization directly to the 3D 
ABX3 perovskite phase.[26]
Although PbX2–DMSO complexes have been known for 
decades, it is unclear how CsI will interact with the solvents, 
and hence might impact crystallization at higher concentra-
tions. For the most commonly used wide-bandgap perov-
skites, FAxCs1−xPb(IyBr1−y)3, typically up to 30% Cs is utilized, 
although up to 50% Cs has been reported.[22,27–29] In applica-
tions where higher temperature operation may be experienced 
or perhaps when organic outgassing is a concern, such as 
operation in space, all-inorganic perovskites may prove to be 
the most useful. Notably, there are no reports of all-inorganic 
CsPbI3 perovskites fabricated with traditional antisolvents, 
and only one report which utilized an air-drying method.[30] 
There has been work on controlling crystallization dynamics 
by the introduction of additives such as hydroiodic acid (HI), 
through templating growth with MAI or Cs4PbI6, or by the use 
of DMA0.3Cs0.7PbI3 with an antisolvent.[31–37] Based on the suc-
cess of the antisolvent technique in mixed A-site perovskites, 
it is noteworthy that there are no reports of antisolvents used 
for pure CsPbI3 perovskites, particularly given that the pro-
posed crystallization mechanism ignores any influence of the 
A-site and is based primarily on PbI2–DMSO interactions. This 
suggests that there is an incomplete understanding of the CsI 
influence on crystallization and how to control it.
Here, we probe the crystallization mechanism for CsPbI3 and 
identify methyl acetate as an effective antisolvent. By studying 
the film adduct chemistry, crystal structure, morphology and 
optoelectronic properties, we demonstrate that CsI complexes 
strongly with DMSO and can fully retard any crystallization. 
Traditional antisolvents, such as toluene or chlorobenzene, do 
not promote heterogeneous nucleation and only antisolvents 
that form an adduct with CsI promote heterogeneous nuclea-
tion and high-quality films. The implications of the CsI com-
plexes are critical to all-inorganic perovskites as well as for the 
mixed cation perovskites, which are the most stable perovskites.
2. Results and Discussion
The requirements for an appropriate antisolvent are to evapo-
rate quickly and be miscible with DMSO and DMF, but poorly 
solvate the perovskite salts. However, the exact antisolvent 
mechanism and preferred physical and/or chemical proper-
ties necessary are unclear. Here, we explore six different anti-
solvents chosen to fully cover the basis of relevant solvent 
parameters: boiling point, vapor pressure, polarity (Hansen 
polar parameter or Gutmann’s donor number), and miscibility 
(Hildebrand parameter) (Table S1, Supporting Information). 
Comparison between no antisolvent (untreated) and the six 
other antisolvents allows us to glean the effect of DMSO and 
the antisolvent influence on nucleation of CsPbI3. Between 
the antisolvents, chlorobenzene (CB) and toluene (Tol) repre-
sent the traditional nonpolar antisolvents, diethyl ether (DEE), 
and anisole help in understanding of the influence of solvent 
removal rate based on differences in boiling point and vapor 
pressure, and ethyl acetate (EtOAc) and methyl acetate (MeOAc) 
probe whether the polarity of the antisolvent aids in nucleation, 
since both are more polar than the traditional antisolvents.
To understand the crystallization dynamics and antisolvent 
mechanism of CsPbI3, the as-quenched films prior to annealing 
were first studied. It has previously been shown that the 
formation of a crystalline intermediate, typically light brown, 
precursor phase is critical in forming high-quality, pinhole-free 
films.[15,38] Without an antisolvent, the CsPbI3 as-quenched, pre-
annealed film retains a yellow color with an absorption onset of 
450 nm (Figure 1A). CB, Tol, and DEE do not change the as-
quenched film from the yellow color (Figure 1C). The yellow 
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color persists regardless of antisolvent timing, suggesting 
that the nucleation window is not being missed (Figure S1, 
Supporting Information), although films eventually turn brown 
over tens of minutes as has been previously reported.[30] Con-
versely, the use of anisole, EtOAc and MeOAc (Figure 1B) all 
turned the as-quenched CsPbI3 film immediately to a brown 
color, with a bandgap of ≈1.72 eV, where EtOAc and anisole 
showed significant scattering backgrounds. 1.72 eV is the 
bandgap typically reported for the CsPbI3 orthorhombic 3D 
perovskite phase and was obtained here at room temperature.[20]
X-ray diffraction (XRD) of the untreated, preannealed films 
(Figure 1D) shows no crystalline peaks, which is in stark con-
trast to that of MAPbI3, which crystallizes into the MAI–PbI2–
DMSO phase without any antisolvent treatment and has a 
strong peak at ≈10° 2θ.[5,11] Recent reports have demonstrated 
that CsI can retard crystallization in mixed A-site perovskites 
by forming a strong adduct with DMSO, and we see that 
crystallization is completely stopped in neat CsPbI3.[25] The 
use of DEE as an antisolvent does not induce crystallization, 
whereas the other two yellow, as-quenched antisolvent treat-
ments, CB and Tol, result in the crystallization of a CsI–PbI2–
DMSO adduct with peaks at 8.5°, 25.5° and 34° 2θ similar to 
MAI–PbI2–DMSO previously reported.[11] All three antisolvents 
that turned the as-quenched films brown, (anisole, EtOAc, and 
MeOAc) created films that show crystalline peaks between 25° 
and 27° 2θ, indicative of the δ-CsPbI3 phase (Figure S2, Sup-
porting Information). This is similar to what has been shown 
for the CsPbI3 solvent-controlled growth method, where the 
dried films turned brown and showed both a nonperovskite 
and perovskite orthorhombic (δ) perovskite CsPbI3 phases.[30] 
However, despite the brown color seen here, we are unable 
to obtain XRD patterns that show any black perovskite phases 
(α, β, nor γ).
To further understand the formation, or lack-thereof, of a 
crystalline precursor phase, the influence of solvent is probed. 
Previous reports that the CsI–DMSO interaction may slow 
down nucleation and the formation of a CsI–PbI2–DMSO pre-
cursor phase suggest that the exact DMSO interaction between 
CsPbI3 and the antisolvent is critical to nucleation and crystalli-
zation. Figure 2 shows the FTIR spectrum of each as-quenched 
film after exposing the sample to vacuum to remove unbound 
solvent and allow for study on the bound solvent species. None 
of the films changed appearance after the vacuum treatment. 
FTIR shows both residual DMF and DMSO at characteristic 
stretching modes of υC=O at ≈1660 cm−1 and υS=O at ≈1000 cm−1, 
respectively, in each antisolvent film.[38,39] It has been previously 
shown that both DMF and DMSO form adducts with perovskite 
precursors, albeit with different strengths.[40–42]
To better quantify the residual DMSO and DMF, 1H NMR 
was performed on as-quenched films by dissolving the films 
in deuterated DMSO-d6. Films were first stored under rough 
vacuum for 3 min and then dissolved to allow us to focus on 
the bound solvent species instead of unbound species. The 
deuterated DMSO-d6 quintet peak is at 2.50 ppm whereas 
the undeuterated DMSO singlet peak is slightly shifted at 
2.54 ppm, allowing us to probe specifically the residual (undeu-
terated) DMSO in the as-quenched films.[43] To quantitatively 
determine the PbIx:DMSO ratio, the intensity of the undeuter-
ated DMSO peak was normalized to the solution PbIx absorb-
ance (Figure 2B, Figure S3, Supporting Information). A small 
amount of DMF was found in each film and the values are all 
approximately the same regardless of antisolvent treatment 
(Table S2, Supporting Information). The residual DMF:DMSO 
ratio in the untreated, as-quenched film is ≈1:15, in stark con-
trast to the starting 4:1 DMF:DMSO ratio. This suggests that 
evaporation during spincoating, not the antisolvent, removes 
most of the DMF. For comparison, the residual bound DMSO 
amount in each as-quenched film was then compared to the 
untreated film (Figure 2C) by normalizing to the DMSO NMR 
peak area in the untreated film. All antisolvent treatments 
removed at least some bound DMSO compared to the untreated 
film, demonstrating that the antisolvent is specifically targeting 
bound DMSO rather than excess solvent in general. However, 
there are no clear trends between color, crystal phase, and 
residual bound DMSO amount. DEE as-quenched films remain 
yellow and amorphous, akin to untreated films but have 66% 
Adv. Energy Mater. 2020, 10, 1903365
Figure 1. Analysis of as-quenched, preannealed films with various anti-
solvent treatments: Untreated (black), CB (purple), Tol (dark blue), 
DEE (turquoise), Anisole (green), EtOAc (orange) and MeOAc (red). 
A) UV–vis absorbance of as-quenched films, representative pictures of 
an B) MeOAc and C) untreated as-quenched film and D) XRD where * 
denotes quartz substrate peak and background amorphous peak from 
the air-free holder was subtracted out with the ICSD XRD pattern for 
δ-CsPbI3, and α-CsPbI3 (gray).
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residual bound DMSO. CB and Tol both form a PbI2–DMSO 
crystalline precursor phase but have large variabilities in the 
relative bound DMSO amounts at 86% and 53%, respectively. 
Anisole, EtOAc and MeOAc all form a brown, δ-CsPbI3 crys-
talline precursor phase and also have large variabilities in the 
relative residual bound DMSO amounts. MeOAc has the lowest 
residual bound DMSO amount at 29%, but EtOAc has a similar 
residual bound DMSO amount to Tol at 47% as does anisole to 
DEE at 70%. Further, there are no clear trends between any of 
the typically cited solvent parameters (boiling point, vapor pres-
sure, miscibility, polarity) and the degree of removal of DMSO 
(Figure S4, Supporting Information). This suggests that the 
typical ways of thinking about the antisolvent mechanism are 
inadequate for CsPbI3.
These antisolvent physical parameters specifically do not 
account for any sort of adduct formation such as PbI2–DMSO, 
which has been identified to strongly influence the crystalliza-
tion dynamics in halide perovskites.[15,40,42,44–48] Basicity scales 
like the Gutmann’s donor notionally account for the strength 
of adduct formation, but is based on adduct formation with a 
model Lewis acid (SbCl5) and does not account for hardness 
or softness of the constituents thus is incomplete.[42] To 
probe adduct formation, FTIR was done on each as-quenched 
CsPbI3 film, as well as as-quenched films where the precursor 
contained only PbI2 or CsI to deconvolute the exact species 
involved in adduct formation. Typically, the A-site is thought to 
be a passive bystander and not play a role in the adduct for-
mation. A DMSO υS=O doublet at ≈975 cm−1 and DMF υC=O 
peak at ≈1660 cm−1 appear in both CsPbI3 and PbI2 untreated 
films (Figure 3A,B) as would be expected due to the known 
PbI2–DMSO adduct formation as well as the weaker PbI2–
DMF adduct.[5,38] Notably, there is also a clear narrow DMSO 
υS=O peak at 1030 cm−1 and a small DMF peak in the CsI film. 
The resulting CsPbI3 DMSO peak appears to be a superposi-
tion of both the PbI2–DMSO and CsI–DMSO, confirming that 
the individual interactions of CsI and PbI2 make up the adduct 
interaction for CsPbI3. The evidence here for a strong CsI–
DMSO adduct demonstrates that CsI–DMSO, and more gener-
ally the A-site, can play an important role in the nucleation and 
crystallization dynamics and should not be ignored. Indeed, 
this correlates well with other observations that a CsI–DMSO 
interaction retards crystallization in mixed A-site perovskites 
and a DMSO-rich preannealed CsPbI3 remains amorphous.[25]
Further inspection of the CsI FTIR for the brown as-quenched 
films (anisole, EtOAc, MeOAc) shows additional peaks beyond 
DMF and DMSO, whereas the yellow as-quenched films (CB, 
Tol, DEE) only show DMF and DMSO (Figure 3C–H, Figure S5, 
Supporting Information). The MeOAc carbonyl group is evident 
in both the CsI and CsPbI3 FTIR spectra at 1740 cm−1, sug-
gesting there is also a CsI–MeOAc adduct that is present in the 
as-quenched CsPbI3 (Figure 3H).[49] This MeOAc peak in CsI is 
slightly shifted from CsPbI3–MeOAc at 1730 cm−1 and shifted 
far from the neat MeOAc peak at 1770 cm−1, again indicative of 
complexation (Figure S5, Supporting Information).[49] Similarly, 
the anisole phenyl group stretch at ≈1600 cm−1 is evident in both 
CsI and CsPbI3 and the EtOAc carbonyl doublet at ≈1730 cm−1 
is only evident in the CsI FTIR spectra (Figure 3F,G). This dem-
onstrates that anisole, EtOAc, and MeOAc act as antisolvents 
in the traditional sense by removing bound solvent, yet also 
form adducts making them a specific type and subset of anti-
solvents, an adduct antisolvent. We note that the formation of 
CsI–antisolvent adducts does not directly correlate with any sol-
vent parameter, such as polarity or Gutmann’s donor number, 
and CsI–acetate adducts have been previously reported in 
CsPbI3 quantum dots (QDs).[50,51] Each antisolvent that forms 
an adduct with CsI (anisole, EtOAc, MeOAc) has a Lewis basic 
oxygen available for adduct formation as does DEE. However, 
Cs+ as a soft acid will preferentially bind to soft bases. Based 
on the polarizability of the Lewis basic oxygens, the softness 
decreases according to MeOAc≈EtOAc>anisole>DEE, thus we 
expect and see that the antisolvent interaction with CsI follows 
this trend.[52] This does not fully explain the removal of bound 
DMSO as Tol removes as much bound DMSO as EtOAc thus 
it is likely a combination of multiple factors. In any scenario, 
the CsI–antisolvent adduct formed is likely driven by significant 
excess of the antisolvent available to bind rather than thermo-
dynamic favorability. The formation of a CsI–antisolvent adduct 
correlates with crystallization in the δ-CsPbI3 phase, regardless 
of the amount of residual bound DMSO in the as-quenched 
film. The introduction of the CsI–antisolvent adduct poten-
tially decreases the energetic barriers for direct formation of 
δ-CsPbI3, similar to what has been previously reported in mixed 
FA/Cs perovskites.[26] This suggests that the CsI–antisolvent 
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Figure 2. Characterization of residual bound DMSO and DMF in 
as-quenched untreated (black), CB (purple), Tol (dark blue), DEE 
(turquoise), anisole (green), EtOAc (orange), and MeOAc (red) films 
by A) FTIR and B) 1H NMR, where gray is the DMSO-d6 NMR solvent. 
C) Relative residual bound DMSO amount found in each as-quenched 
film normalized to the untreated DMSO amount.
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adduct influences crystallization more so than the CsI–DMSO 
or PbI2–DMSO adduct.
To understand the impact of CsI–antisolvent adduct for-
mation on nucleation, the as-quenched films were annealed 
at 330 °C for 90 s and the resulting film morphology was 
captured by scanning electron microscopy (SEM) (Figure 4). 
All of the yellow as-quenched films (untreated, CB, Tol, DEE) 
show both areas of large apparent grains and large pinholes, 
with some needle-like morphologies indicative of PbI2-domi-
nated growth.[13,53] There are more needle-like morphologies 
in films made with CB and Tol, which correlate well with the 
pre-annealed PbI2–DMSO crystalline adduct seen in XRD. 
Although untreated and DEE films were both amorphous 
as-quenched, the postanneal morphologies are quite different, 
suggesting that the differences in residual DMSO play a large 
role in the morphology, as previously demonstrated.[33] The DEE 
film has many very large apparent grains (>20 µm), but also has 
many large pinholes as compared to the untreated sample. Both 
large grains and large pinholes are indicative of uncontrolled 
growth, which likely occurs when the majority of residual 
bound DMSO is removed via annealing. Anisole, EtOAc and 
MeOAc all formed an as-quenched crystalline δ-CsPbI3 film, 
but with significantly different morphologies. The annealed 
anisole film appears to nucleate in many places based on the 
lack of large grains and absence of needle-like morphologies, 
however the apparent grain domains are small and there are 
large pinholes. Films made with anisole had a relatively high 
amount of residual bound DMSO in the as-quenched films, 
suggesting that higher amounts of residual bound DMSO still 
retard nucleation and can negatively impact morphology. The 
film morphology of both EtOAc and MeOAc shows compact, 
pinhole free films with large grain domains. The apparent grain 
boundaries in the EtOAc film are hard to distinguish, but in 
MeOAc they are clear with grain domains up to ≈10 µm large. 
Only EtOAc and MeOAc films have clean absorbance spectra 
with minimal scattering backgrounds, whereas all other films 
show significant scattering backgrounds (Figure S6, Supporting 
Information). Both EtOAc and MeOAc as-quenched films 
have the least amount of residual bound DMSO and form the 
δ-CsPbI3 crystal phase. The interplay between the crystalliza-
tion phase, as controlled by the CsI–antisolvent adduct, and the 
amount of residual bound DMSO or antisolvent at nucleation 
controls the resulting morphology, demonstrating that both are 
required for the fabrication of high-quality CsPbI3 films.
Solar cells were then made with CsPbI3 prepared using each 
different antisolvent. MeOAc devices had the highest cham-
pion efficiency of 14.4% and an average of 12.95% (Figure 5A). 
A high JSC of 18.93 mA cm−2 was achieved due to 88% max-
imum EQE, although the VOC was slightly low at 0.998 V. This 
efficiency is respectable for all-inorganic CsPbI3 devices consid-
ering there are no additional organic additives nor HI which 
may react with DMF and incorporate as DMAI.[37] CsPbI3 solar 
cells made without the use of any additional organic additives 
have reached a champion efficiency of 15.7% and a recent 
report of 14.1%, although with organic additives efficiencies of 
18.4% have been reported, but the latter are no longer all-inor-
ganic CsPbI3 devices.[30,31,36] MeOAc has recently been reported 
as an effective antisolvent for DMA0.1FA0.6Cs0.3Pb(I0.8Br0.2)3 
yielding device efficiencies of 19.2%, suggesting that MeOAc 
can be effectively used in other Cs-rich perovskites.[21] EtOAc 
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Figure 3. FTIR probing DMSO and antisolvent complexation to CsI (dotted), PbI2 (dashed) and CsPbI3 (solid) for A,B) Untreated, C) CB, D) Tol, 
E) DEE, F) anisole, G) EtOAc and H) MeOAc where * denotes antisolvent peak in CsPbI3 FTIR spectra. υ denotes a stretching mode and δ is a bending 
mode. Schematic of I) CsI–DMSO adduct formation in the PbI2–DMSO crystal structure and J) CsI–MeOAc adduct formation in the δ-CsPbI3 crystal 
structure with the PbI64− octahedra (blue diamonds), Cs (pink circles), DMSO (black chemical structure), and MeOAc (red chemical structure).
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devices reach the second highest PCE of 13.2% although the 
average was only 9.84% due to large variations in performance 
influenced by the solvent glovebox atmosphere (Figure 5B and 
Figures S7 and S8, Supporting Information). EtOAc has also 
been reported as an effective antisolvent for CsPbI2Br.[54] All 
other antisolvents resulted in champion efficiencies (Figure 5B 
and Figures S7 and S9, Supporting Information) less than 10%, 
due to significant losses in JSC, VOC, and FF. Notably, the third 
highest performing antisolvent treatment was untreated at a 
champion efficiency of 9.96%, with a JSC of 17.67 mA cm−2, 
a VOC of 0.899 V and a FF of 62.7%, demonstrating that the 
addition of any antisolvent is not necessarily beneficial and can 
limit device performance. This underscores the importance of 
understanding the antisolvent mechanism in order to maxi-
mize device performance.
Clearly, the losses in PCE for the untreated devices as com-
pared to MeOAc are in part due to the large density of pinholes, 
which allows for contact between the electron and hole transport 
layers, decreasing VOC and FF by reducing shunt resistance. 
The large distribution in efficiencies is also due to the poor 
film coverage, and not to phase degradation (Figure S9, 
Supporting Information). This is also true for CB, Tol, DEE 
and anisole. While egregious pinholes do lower JSC, the 
decrease in absorbance does not fully account for the loss in 
JSC (Figure S6, Supporting Information). To better understand 
the optoelectronic properties of antisolvent treated CsPbI3 
films, time-resolved photo luminescence (TRPL) was done 
(Figure S10, Supporting Information). The TRPL lifetimes for 
untreated and CB are similar at 1.4 and 2.2 ns respectively, 
whereas the use of MeOAc triples the lifetime to 6.4 ns, dem-
onstrating that film formation through a CsI–MeOAc adduct 
results in a film with lower defect density. Although these life-
times are very short, they are on par with other reported values 
in similarly performing solar cells.[31] Second, the normalized 
EQE was studied, where the relative intensity of the EQE at the 
band edge compared to the EQE within the bandgap is an indi-
cation of the trap state density at the band edge (Figure S11, 
Supporting Information). This analysis aids in deconvoluting 
low device efficiency due to large pinholes versus lower mate-
rial quality. MeOAc maintains 98% of the maximum EQE at 
the band edge, whereas EtOAc, anisole, and untreated all have 
similar losses at 90–88%. CB, Tol and DEE have much higher 
losses at the band edge of 82%, 54%, 69% respectively. These 
values correlate well with the relative JSC for each antisolvent, 
demonstrating that the band edge absorption is mainly limiting 
the JSC. Although CsPbI3 device operational stability is outside 
Adv. Energy Mater. 2020, 10, 1903365
Figure 5. Photovoltaic performance of CsPbI3 devices. A) PCE distri-
bution for devices made with each antisolvent B) champion JV curve, 
C) stabilized power output (SPO) as measured by max power point 
(MPP) tracking D) EQE and E) distribution of efficiencies for 46 devices 
made with MeOAc.
Figure 4. SEM of an annealed film fabricated using each antisolvent treatment, A) Untreated, B) CB, C) Tol, D) DEE, E) Anisole, F) EtOAc, and 
G) MeOAc with a 20 µm scale bar.
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of the scope of this work, there are many methods used to 
improve stability which could synergistically be combined with 
this work to further improve stability.[34,35,55–58]
3. Conclusions
CsPbI3 crystallization is not only controlled by the PbI2–DMSO 
adduct, but also by the A-site interaction with both DMSO and 
the antisolvent adduct. The demonstration that CsI, or more 
generally the A-site cation, can significantly impact nuclea-
tion demonstrates the complexity of nucleation and crystal-
lization not previously understood. Here, we have shown in 
depth exactly how the CsI adducts control nucleation and 
crystallization and have identified the use of a CsI–antisolvent 
adduct to promote the nucleation of high-quality films. Spe-
cifically, MeOAc quenched films result in devices that are both 
the highest efficiency at 14.4% and have the lowest standard 
deviation. MeOAc is also a green, nontoxic solvent. By demon-
strating that the antisolvent controls nucleation and crystalliza-
tion beyond supersaturation for CsPbI3, we expect that these 
techniques will be translated to other CsI-rich mixed A-site 
perovskites and aid in fabricating higher quality wide bandgap 
perovskites for use in multi-junction perovskite cells and used 
in conjunction with known methods to improve CsPbI3 stability.
4. Experimental Section
Materials: All chemicals were used as received. PbI2 (99.99%) was 
bought from TCI. SnO2 colloid precursor (Tin(iv) oxide, 15% in H2O 
colloidal dispersion) was purchased from Alfa Aesar. Spiro-OMeTAD was 
purchased from Lumtec. Tris(2-(1H-pyrazol-1-yl)- 4-tert-butylpyridine)
cobalt(iii)-tris(bis(trifluoromethylsulfonyl)imide): Co[t-BuPyPz]3[TFSI]3 
(Co-FK209) was purchased from Dyesol. All other chemicals were 
purchased from Sigma-Aldrich.
CsPbI3 Film Deposition: Deposition of perovskite was done in a 
nitrogen glovebox. The precursor solution is a 1 m solution with a 
1:1.05 CsI:PbI2 mole ratio in a 4:1 DMF:DMSO solvent mixture. The 
solution was vortexed until dissolved and filtered using a 200 nm nylon 
filter before deposition. The films were deposited by spincoating 45 µL 
of solution at 1500 r.p.m. for 45 s and with 10 s of time remaining in 
the spin procedure 150 µL of antisolvent was added, unless otherwise 
specified. When MeOAc or EtOAc were used as the antisolvent the films 
immediately turn brown. The films were annealed at 330 °C and once 
the films turn dark brown (after ≈1 min) they were annealed for another 
90 s.
Device Fabrication: Patterned ITO glass was cleaned by sonication 
in isopropanol and ultraviolet-ozone cleaning for 15 min. A 4:1 
(wt/wt) H2O:SnO2 nanoparticle solution was spin cast at 3000 r.p.m. for 
30 s and then dried at 150 °C for 30 min. Immediately before perovskite 
deposition, the films were cleaned by ultraviolet-ozone for 15 min. 
Perovskite deposition was done as detailed above. The Spiro-OMeTAD 
solution consists of 72 mg mL−1 Spiro-OMeTAD, 28.8 µL mL−1 tBP, 
17.5 µL LiTFSI stock solution (520 mg mL−1 in acetonitrile) and 5 µL 
of Co-FK209 stock solution (300 mg mL−1 in acetonitrile). The Spiro-
OMeTAD solution was deposited on top of the perovskite in a nitrogen 
glovebox by spinning at 5000 r.p.m. for 30 s. 15 nm of MoOx and 100 nm 
of Al were thermally evaporated.
Film Characterization: UV–vis of as-quenched samples on glass was 
done utilizing a Hewlett-Packard 8453 UV–vis spectrophotometer.
For X-ray diffraction, the as-quenched were deposited on quartz 
substrates. Samples were sealed inside Anton Paar domed sample 
holders in a N2-filled glovebox and measured using a Panalytical 
X’pert powder diffractometer with Cu anode. Up to four scans were 
measured and averaged for each film to improve the signal-to-noise. The 
amorphous background from the polycarbonate dome was subtracted 
from each pattern.
FTIR measurements were done in an Ar glovebox on a Bruker 
Alpha FTIR spectrometer using a diffuse reflectance infrared Fourier 
transform spectrometer (DRIFTS) attachment with a resolution of 
4 cm−1. Background measurements were taken on blank substrates 
and subsequent sample measurements were taken as an average of 
24 scans. Spectra were baseline-corrected using the concave rubberband 
correction method. As quenched films were deposited on gold-coated, 
polished Si wafer substrates and cycled under vacuum for 9 min before 
FTIR was taken. A 1 m CsI in 4:1 DMF:DMSO solution and 1 m PbI2 
4:1 DMF:DMSO solution were used for the as quenched CsI and PbI2 
controls and deposited the same way as CsPbI3.
Samples for NMR were prepared by fabricating as quenched films 
on glass slides. The films were then put under vacuum for ≈3 min to 
remove any surface adsorbed (unbound) species and then redissolved 
using deuterated DMSO-d6. A total of five films were used to reach an 
appropriate concentration. 1H spectra were recorded using a JEOL ECA-
500 at room temperature, and referenced to the absolute integrals of the 
DMF (7.959–7.936 ppm) and DMSO peaks (singlet, 2.573–2.524 ppm). 
The raw data was then normalized to the PbIX solution absorbance, as 
measured using a Shimadzu UV-3600 ultraviolet–visible–near infrared 
spectrophotometer. This controls for any variations in solution PbIX 
concentration. For ease of comparison, these values for each antisolvent 
treatment were then compared as a percent of residual DMSO in the 
untreated film.
SEM was done on annealed films in a Hitachi S-4800 field emission 
scanning electron microscope.
Time-resolved photoluminescence (TRPL) films were measured using 
a supercontinuum fiber laser (NKT Photonics, Super K) operating at 
5 MHz as the excitation source. Films were excited at 500 nm at a low 
fluence (<<1015 s−1) and a Hamamatsu C10910−04 streak camera was 
used to collect time-resolved spectra. Bi-exponential fits of the TRPL 
decays were weighted to calculate the average PL lifetime using the 
equation: τavg  = (A0τ0 + A1τ1)/(A0 + A1).
Device Characterization: Devices were tested in a nitrogen glovebox 
using a Newport Oriel Sol3A solar simulator with a xenon lamp where 
the intensity was calibrated to 100 mW cm−2 AM1.5G using a KG2 filtered 
NREL-certified mono-Si reference solar cell. JV scans were taken from 
forward bias to reverse bias with the following scan parameters at a scan 
rate of 0.51 V s−1 with a step size of 23 mV. The devices were ≈0.1 cm2  
and were masked with a metal aperture to define an active area of 
0.058 cm2. Stable power output (SPO) was measured by recording the 
current output when the illuminated device was held at a constant voltage 
near the maximum power point of the JV scan. Maximum power point 
(MPP) tracking was measured similarly, but the voltage was allowed to 
float. EQE measurements were taken using a Newport Oriel IQE2.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
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